Details of the Drug Formulaction

General Information of Drug Formulation (ID: F03185)

• Formulation Name: Canagliflozin 100 mg tablet
• Company: Janssen Pharmaceutical

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Canagliflozin	(DMFRM1I)	Type-2 diabetes	5A11	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Carmellose sodium	(E00625)	Not Available	Disintegrant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 3350	(E00652)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Water	(E00035)	962	Solvent